Ind-Swift Laboratories Ltd 2023 AR2
The report highlights Ind-Swift Laboratories Limited's financial and operational performance for the fiscal year 2022-2023, showcasing a strong recovery with high double-digit topline growth and record EBITDA. The company expanded its global footprint, exporting active pharmaceutical ingredients (APIs) to over 70 countries, and advanced its CRAMS and forward integration initiatives. On the sustainability front, Ind-Swift focused on environmental stewardship through planned improvements in solvent recovery and energy efficiency, alongside social initiatives like the NALANDA skill development program for rural youth.
Company: Ind-Swift Laboratories Ltd
Sector: Manufacturing
Country: India
Year: 2023
Type: AR2
Pages: 200
Back to company
Ind-Swift Laboratories Ltd
Annual Report
The report highlights Ind-Swift Laboratories Limited's financial and operational performance for the fiscal year 2022-2023, showcasing a strong recovery with high double-digit topline growth and record EBITDA. The company expanded its global footprint, exporting active pharmaceutical ingredients (APIs) to over 70 countries, and advanced its CRAMS and forward integration initiatives. On the sustainability front, Ind-Swift focused on environmental stewardship through planned improvements in solvent recovery and energy efficiency, alongside social initiatives like the NALANDA skill development program for rural youth.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Apr 1, 2022 - Mar 31, 2023
Fiscal Year
2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees